Ahmed El Ghamry Sabe, MD
Cardiovascular Disease · Canton, OHNPI 1679555890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Cardinal Health 200 LLC at 29.6% of the total. Reporting peaked in 2020 at $236 and has fallen 68.0% since, to $76 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in OH, where the typical reported total is $1,347.
Across 20 payments — averaging $30.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 200 LLC$181
- Regeneron Healthcare Solutions, Inc.$169
- Boston Scientific$129
- Abbott$76
- Abiomed$30
- Terumo Medical Corporation$24
- plus $4 from 1 others
What the payments were for
- Consulting fees$41%
- Food & beverage$60999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 200 LLC | 13 | $181 |
| Regeneron Healthcare Solutions, Inc. | 2 | $169 |
| Boston Scientific | 1 | $129 |
| Abbott | 1 | $76 |
| Abiomed | 1 | $30 |
| Terumo Medical Corporation | 1 | $24 |
| Z-medica, LLC | 1 | $4 |
How this compares
$613 in reported general payments places this provider in the 35th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $11,325 |
| ClopidogrelClopidogrel Bisulfate | 58 | $601 |
| Metformin Hcl | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Canton
- Steven HirschCanton$46K
- Guilherme AttizzaniCleveland$1.3M
- Gregory LamCircleville$428K
- Emil HayekHudson$379K
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Kamal ShemisaCincinnati$314K
- Mehdi ShishehborElyria$237K
- Abdu HawwaGarfield Hts$234K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.